Biological products are therapeutic agents produced using a living system or organism. In many cases, access to these products is limited due to their expensive cost (Chow et al., 2011). A biosimilar is a biological product that is highly similar (not identic) to, and has no clinically meaningful differences from, an existing reference biological product on the market (Desai et al., 2020). “Non-medical” switching is the switching of a patient's medicine for reasons other than the patient's health and safety, like the reduction of costs (Dolinar et al., 2019).
Mazzoni D., Vener C., Mazzocco K., Monzani D., Pravettoni G. (2021). The Psychological Risks Associated With the Non-medical Switch From Biologics to Biosimilars. FRONTIERS IN PSYCHOLOGY, 12 [10.3389/fpsyg.2021.605643].
The Psychological Risks Associated With the Non-medical Switch From Biologics to Biosimilars
Monzani D.;
2021-01-01
Abstract
Biological products are therapeutic agents produced using a living system or organism. In many cases, access to these products is limited due to their expensive cost (Chow et al., 2011). A biosimilar is a biological product that is highly similar (not identic) to, and has no clinically meaningful differences from, an existing reference biological product on the market (Desai et al., 2020). “Non-medical” switching is the switching of a patient's medicine for reasons other than the patient's health and safety, like the reduction of costs (Dolinar et al., 2019).File | Dimensione | Formato | |
---|---|---|---|
The Psychological Risks Associated With the Non-medical Switch From Biologics to Biosimilars.pdf
accesso aperto
Tipologia:
Versione Editoriale
Dimensione
147.26 kB
Formato
Adobe PDF
|
147.26 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.